Abstract
A comprehensive review of ROS-activated produg strategies for targeted therapy, including state-of-the-art and future perspectives.
Funding Information
  • Novo Nordisk Fonden
  • Danmarks Tekniske Universitet
  • Teknologi og Produktion, Det Frie Forskningsråd (7017-00026)

This publication has 142 references indexed in Scilit: